(Q34470910)

2 August 2017

mGluR2/3 blockade produces rapid and long-lasting reversal of anhedonia caused by chronic stress exposure (English)

1 reference

2 August 2017

1 reference

3

Ronald S Duman

1 reference

2 August 2017

1

Jason M Dwyer

1 reference

2 August 2017

2

Ashley E Lepack

1 reference

PubMed ID

25408908

2 August 2017

language of work or name

1 reference

17 September 2013

1 reference

Journal of molecular psychiatry

2 August 2017

1 reference

2 August 2017

1

1 reference

2 August 2017

1

1 reference

2 August 2017

15

1 reference

https://scigraph.springernature.com/pub.10.1186/2049-9256-1-15

2 August 2017

0 references

cites work

mTOR activation is required for the antidepressant effects of mGluR₂/₃ blockade

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4224009

Involvement of the mammalian target of rapamycin signaling in the antidepressant-like effect of group II metabotropic glutamate receptor antagonists

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4224009

Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4224009

Rapid microelectrode measurements and the origin and regulation of extracellular glutamate in rat prefrontal cortex

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4224009

mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4224009

Metabotropic glutamate2/3 (mGlu2/3) receptors, schizophrenia and cognition

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4224009

Behavioral characterization of the mGlu group II/III receptor antagonist, LY-341495, in animal models of anxiety and depression

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4224009

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4224009

MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4224009

The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4224009

Antidepressant effects of ketamine in depressed patients

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4224009

2-substituted (2SR)-2-amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 2. Effects of aromatic substitution, pharmacological characterization, and bioavailability.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4224009

Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4224009

Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4224009

Distribution of the messenger RNA for a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4224009

AMPA receptor stimulation mediates the antidepressant-like effect of a group II metabotropic glutamate receptor antagonist

6 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F2049-9256-1-15

Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F2049-9256-1-15

Distribution of the mRNA for a metabotropic glutamate receptor (mGluR3) in the rat brain: an in situ hybridization study

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25408908

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Pre- and postsynaptic localization of a metabotropic glutamate receptor, mGluR2, in the rat brain: an immunohistochemical study with a monoclonal antibody

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25408908

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Pharmacological validation of the chronic mild stress model of depression

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25408908

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/2049-9256-1-15

1 reference

PubMed ID

25408908

Dimensions Publication ID

2 August 2017

0 references

1 reference

2 August 2017

1 reference

PubMed ID

25408908